Uptravi 200 mcg

UPTRAVI 200 MCG tablets contain the active ingredient selecipag, used for managing certain conditions related to blood vessel function. This medication is designed to support cardiovascular health and improve quality of life.

UPTRAVI 200 MCG tablets are primarily used to treat conditions associated with pulmonary arterial hypertension. Selexipag, the active ingredient, works by helping to relax and widen blood vessels, which can improve blood flow and reduce symptoms. This medication is often prescribed to manage symptoms and enhance daily functioning in patients with specific cardiovascular issues.

Common effects of UPTRAVI 200 MCG tablets may include headaches, nausea, and dizziness. Some users might experience flushing or gastrointestinal discomfort. These effects vary among individuals and are generally mild to moderate in nature.

UPTRAVI 200 MCG tablets should be handled with care, following the guidance of a healthcare professional. It is important to store the medication properly and adhere to the prescribed regimen. Patients should inform their healthcare provider about any existing medical conditions or allergies before starting this medication.

UPTRAVI 200 MCG tablets may interact with certain medications, including those metabolized by the liver's CYP enzymes. It is advisable to consult a healthcare professional before combining this medication with other treatments. Alcohol and certain supplements may also affect the efficacy or safety of selecipag.